LARIMAR THERAPEUTICS, INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $85.4M | $33.2M | $26.7M | $26.8M | $70.1M | $68.1M | $1.0M | $49.3M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $142.0M | $195.3M | $90.2M | $120.7M | $72.2M | $98.0M | $4.8M | $121.3M |
| Property, Plant & Equipment | $622.0K | $881.0K | $684.0K | $831.0K | $1.0M | $1.0M | $274.0K | $375.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $145.8M | $200.2M | $95.9M | $126.4M | $78.7M | $104.7M | $5.2M | $121.8M |
| Liabilities | ||||||||
| Accounts Payable | $5.2M | $2.4M | $1.3M | $1.7M | $1.7M | $2.6M | $3.5M | $3.6M |
| Total Current Liabilities | $64.8M | $24.4M | $9.5M | $10.7M | $8.8M | $9.0M | $5.9M | $13.3M |
| Long-Term Debt | — | — | — | — | — | — | $14.5M | $20.0M |
| Total Liabilities | $67.8M | $28.4M | $14.2M | $15.5M | $14.3M | $15.0M | $5.9M | $28.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-434.8M | $-269.2M | $-188.6M | $-151.6M | $-116.3M | $-65.6M | $-23.1M | $-350.9M |
| Total Stockholders' Equity | $78.1M | $171.8M | $81.7M | $110.9M | $64.4M | $89.7M | $-694.0K | $2.9M |